Suppr超能文献

日本京都地区万古霉素耐药屎肠球菌和粪肠球菌的分布和控制。

Regional spread and control of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Kyoto, Japan.

机构信息

Department of Infection Control and Prevention, Kyoto University Hospital, 54 Shogoin-Kawaharacho, Sakyo, Kyoto, 6068507, Japan.

出版信息

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):1095-100. doi: 10.1007/s10096-011-1412-x. Epub 2011 Oct 4.

Abstract

The purpose of this investigation was to control the post-outbreak prevalence of vancomycin-resistant enterococci (VRE) in the affected Kyoto region. The study period was from 2005 to 2010. Faecal samples were subjected to VRE screening, and vancomycin resistance genes were detected by polymerase chain reaction (PCR). The genotype was determined by pulsed-field gel electrophoresis (PFGE) of genomic DNA digested with SmaI and by multilocus sequence typing (MLST). A VRE control programme was established in 2006, consisting of a laboratory-based faecal VRE screening system, annual surveillance of hospital inpatients and the promotion of adequate infection control measures. vanA-Enterococcus faecium, vanB-E. faecium and vanB-E. faecalis were detected at 35, 12 and 5 hospitals, respectively. Genotype analysis revealed that all of the vancomycin-resistant E. faecium isolates obtained since 2005 belonged to ST78, and that clonally related vanB-E. faecalis of ST64 had spread to three hospitals. The rate of faecal VRE carriage among the patients enrolled in the annual surveillance increased until 2007, when it reached 24 (1.2%) of the 2,035 enrolled patients. The rate began to decrease in 2008 and, by 2010, reached a low of 4 (0.17%) of the 2,408 enrolled patients. While VRE did spread within the Kyoto region, the VRE control programme succeeded in controlling the overall VRE spread.

摘要

本研究旨在控制受影响的京都地区爆发后耐万古霉素肠球菌(VRE)的流行情况。研究期间为 2005 年至 2010 年。采集粪便样本进行 VRE 筛查,并通过聚合酶链反应(PCR)检测万古霉素耐药基因。通过 SmaI 消化的基因组 DNA 的脉冲场凝胶电泳(PFGE)和多位点序列分型(MLST)确定基因型。2006 年建立了 VRE 控制计划,包括基于实验室的粪便 VRE 筛查系统、对住院患者的年度监测以及促进充分的感染控制措施。在 35、12 和 5 家医院分别检测到 vanA-肠球菌 faecium、vanB-肠球菌 faecium 和 vanB-粪肠球菌。基因分析显示,自 2005 年以来获得的所有耐万古霉素粪肠球菌分离株均属于 ST78,并且具有克隆相关性的 vanB-粪肠球菌 ST64 已传播至 3 家医院。年度监测中纳入的患者粪便 VRE 携带率在 2007 年达到高峰,为 24 例(1.2%),共纳入 2035 例患者。2008 年开始下降,到 2010 年,共纳入 2408 例患者,降至 4 例(0.17%)。尽管 VRE 在京都地区内传播,但 VRE 控制计划成功地控制了总体 VRE 传播。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验